Expensify (NASDAQ:EXFY) versus Advanced Human Imaging (NASDAQ:AHI) Head to Head Comparison

Advanced Human Imaging (NASDAQ:AHIGet Rating) and Expensify (NASDAQ:EXFYGet Rating) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, profitability, valuation and earnings.

Insider and Institutional Ownership

0.2% of Advanced Human Imaging shares are held by institutional investors. Comparatively, 51.2% of Expensify shares are held by institutional investors. 16.0% of Advanced Human Imaging shares are held by insiders. Comparatively, 21.1% of Expensify shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Advanced Human Imaging and Expensify, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Advanced Human Imaging 0 0 1 0 3.00
Expensify 0 0 7 0 3.00

Advanced Human Imaging currently has a consensus target price of $11.00, suggesting a potential upside of 1,505.84%. Expensify has a consensus target price of $24.86, suggesting a potential upside of 59.34%. Given Advanced Human Imaging’s higher probable upside, analysts plainly believe Advanced Human Imaging is more favorable than Expensify.

Valuation & Earnings

This table compares Advanced Human Imaging and Expensify’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Advanced Human Imaging $1.20 million 13.72 -$14.06 million N/A N/A
Expensify $142.84 million 7.45 -$13.56 million ($1.19) -13.11

Expensify has higher revenue and earnings than Advanced Human Imaging.

Profitability

This table compares Advanced Human Imaging and Expensify’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Advanced Human Imaging N/A N/A N/A
Expensify -27.02% 18.66% 5.05%

Summary

Expensify beats Advanced Human Imaging on 7 of the 10 factors compared between the two stocks.

About Advanced Human Imaging

(Get Rating)

Advanced Human Imaging Limited operates as a mobile application and technology development company worldwide. It develops and patents a proprietary measurement/dimensioning technology that enables end-user to check, track, and assess body dimensions privately using a smartphone. The company offers smartphone-based human scanning technology, such as BodyScan, FaceScan, DermaScan, MKScan, and HemaScan. It serves mobile health and telehealth, life and health insurance, fitness and wellness, and consumer apparel sectors. The company was formerly known as MyFiziq Limited and changed its name to Advanced Human Imaging Limited in March 2021. Advanced Human Imaging Limited was incorporated in 2014 and is based in South Perth, Australia.

About Expensify

(Get Rating)

Expensify, Inc. provides a cloud-based expense management software platform to individuals, small businesses, and corporations in the United States and internationally. The company's platform enables users to manage corporate cards, pay bills, generate invoices, collect payments, and book travel. It also offers track and submit plans for individuals. The company was founded in 2008 and is based in Portland, Oregon.

Receive News & Ratings for Advanced Human Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Human Imaging and related companies with MarketBeat.com's FREE daily email newsletter.